List of Contributions

Charlotte Marcoux

Contact Details

United States

Contributions

1 to 5 of 7 total

Associate Director, Regulatory Affairs Opportunity

Posted By Charlotte Marcoux 20-Feb-2019 14:36
Found In Egroup: Boston Chapter \ view thread
The Company X4 is an innovative, clinical-stage biotechnology company located in Cambridge, MA dedicated to developing novel immunotherapies primarily for the treatment of cancer. The company is developing therapeutics designed to improve immune cell trafficking and increase the ability for T-cells ...

Senior Director, Regulatory Affairs Opportunity

Posted By Charlotte Marcoux 20-Feb-2019 14:35
Found In Egroup: Boston Chapter \ view thread
The Company X4 is an innovative, clinical-stage biotechnology company located in Cambridge, MA dedicated to developing novel immunotherapies primarily for the treatment of cancer. The company is developing therapeutics designed to improve immune cell trafficking and increase the ability for T-cells ...

Director, Regulatory Affairs Opportunity

Posted By Charlotte Marcoux 20-Feb-2019 14:34
Found In Egroup: Boston Chapter \ view thread
The Company X4 is an innovative, clinical-stage biotechnology company located in Cambridge, MA dedicated to developing novel immunotherapies primarily for the treatment of cancer. The company is developing therapeutics designed to improve immune cell trafficking and increase the ability for T-cells ...

Senior Director, Regulatory Affairs Opportunity

Posted By Charlotte Marcoux 22-Jan-2019 11:55
Found In Egroup: Boston Chapter \ view thread
The Company X4 is an innovative, clinical-stage biotechnology company located in Cambridge, MA dedicated to developing novel immunotherapies primarily for the treatment of cancer. The company is developing therapeutics designed to improve immune cell trafficking and increase the ability for T-cells ...

Director, Regulatory Affairs Opportunity

Posted By Charlotte Marcoux 22-Jan-2019 11:55
Found In Egroup: Boston Chapter \ view thread
The Company X4 is an innovative, clinical-stage biotechnology company located in Cambridge, MA dedicated to developing novel immunotherapies primarily for the treatment of cancer. The company is developing therapeutics designed to improve immune cell trafficking and increase the ability for T-cells ...